Improvement of health status evaluated by Arthritis Impact Measurement Scale 2 (AIMS-2) and Short Form-36 (SF-36) in patients with rheumatoid arthritis treated with tocilizumab

Author： Fusama Mie  

Publisher： Springer Publishing Company

ISSN： 1439-7595

Source： Modern Rheumatology, Vol.23, Iss.2, 2013-03, pp. : 276-283

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of the Arthritis Impact Measurement Scales (AIMS2) in Finnish patients with rheumatoid arthritis

By Arkela-Kautiainen M   Kauppi M   Heikkilä S   Kautiainen H   Mälkiä E   Leirisalo-Repo M  

Scandinavian Journal of Rheumatology, Vol. 32, Iss. 5, 2003-10 ,pp. : 300-305

Informa Healthcare

Access to resources Recommend Favorite

Tocilizumab: a new form of biological therapy for rheumatoid arthritis

By Balint Geza P   Balint Peter V  

Future Rheumatology, Vol. 2, Iss. 4, 2007-08 ,pp. : 361-371

Future Medicine

Access to resources Recommend Favorite

Necrotizing fasciitis in a patient with rheumatoid arthritis treated with tocilizumab

By Yoshida Akiko  

Modern Rheumatology, Vol. 22, Iss. 2, 2012-04 ,pp. : 317-318

Springer Publishing Company

Access to resources Recommend Favorite

Health-related quality of life in primary Sjögren's syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36

By Strömbeck B.   Ekdahl C.   Manthorpe R.   Wikström I.   Jacobsson L.  

Scandinavian Journal of Rheumatology, Vol. 29, Iss. 1, 2000-02 ,pp. : 20-28

Informa Healthcare

Access to resources Recommend Favorite

Structural damages disturb functional improvement in patients with rheumatoid arthritis treated with etanercept

By Tanaka Yoshiya  

Modern Rheumatology, Vol. 22, Iss. 2, 2012-04 ,pp. : 186-194

Springer Publishing Company

Access to resources Recommend Favorite